Shopping Cart 0
Cart Subtotal
AED 0

Global Low Molecular Weight Heparin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 35819
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

Scope of the Report:

In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second's largest market with the share of 30.49%.

At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.

China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.

In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.

Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.

The worldwide market for Low Molecular Weight Heparin is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 380 million USD in 2024, from 270 million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Low Molecular Weight Heparin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Aspen

Sanofi-aventis

Pfizer

Opocrin

CSBIO

Dongying Tiandong Pharmaceutical

Changzhou Qianhong Bio-pharma

Techdow

Yantai Dongcheng Pharmaceutical Group

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Enoxaparin

Dalteparin

Tinzaparin

Fraxiparine

Market Segment by Applications, can be divided into

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Low Molecular Weight Heparin product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin, with price, sales, revenue and global market share of Low Molecular Weight Heparin in 2017 and 2018.

Chapter 3, the Low Molecular Weight Heparin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Low Molecular Weight Heparin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Low Molecular Weight Heparin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Low Molecular Weight Heparin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Low Molecular Weight Heparin Introduction

1.2 Market Analysis by Type

1.2.1 Enoxaparin

1.2.2 Dalteparin

1.2.3 Tinzaparin

1.2.4 Fraxiparine

1.3 Market Analysis by Applications

1.3.1 Treatment of Venous Thromboembolism

1.3.2 Complications of Pregnancy

1.3.3 Cardioversion of Atrial Fibrillation/Flutter

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Aspen

2.1.1 Business Overview

2.1.2 Low Molecular Weight Heparin Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Aspen Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Sanofi-aventis

2.2.1 Business Overview

2.2.2 Low Molecular Weight Heparin Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Pfizer

2.3.1 Business Overview

2.3.2 Low Molecular Weight Heparin Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Opocrin

2.4.1 Business Overview

2.4.2 Low Molecular Weight Heparin Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 CSBIO

2.5.1 Business Overview

2.5.2 Low Molecular Weight Heparin Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Dongying Tiandong Pharmaceutical

2.6.1 Business Overview

2.6.2 Low Molecular Weight Heparin Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Changzhou Qianhong Bio-pharma

2.7.1 Business Overview

2.7.2 Low Molecular Weight Heparin Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Techdow

2.8.1 Business Overview

2.8.2 Low Molecular Weight Heparin Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Techdow Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Yantai Dongcheng Pharmaceutical Group

2.9.1 Business Overview

2.9.2 Low Molecular Weight Heparin Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Low Molecular Weight Heparin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Low Molecular Weight Heparin Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Low Molecular Weight Heparin Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Low Molecular Weight Heparin Manufacturer Market Share in 2018

3.3.2 Top 6 Low Molecular Weight Heparin Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Low Molecular Weight Heparin Market Analysis by Regions

4.1 Global Low Molecular Weight Heparin Sales, Revenue and Market Share by Regions

4.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Regions (2014-2019)

4.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Regions (2014-2019)

4.2 North America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

4.3 Europe Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

4.5 South America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

5 North America Low Molecular Weight Heparin by Country

5.1 North America Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

5.1.1 North America Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

5.1.2 North America Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

5.2 United States Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

5.3 Canada Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

5.4 Mexico Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6 Europe Low Molecular Weight Heparin by Country

6.1 Europe Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

6.1.1 Europe Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

6.1.2 Europe Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

6.2 Germany Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6.3 UK Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6.4 France Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6.5 Russia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6.6 Italy Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7 Asia-Pacific Low Molecular Weight Heparin by Country

7.1 Asia-Pacific Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

7.2 China Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7.3 Japan Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7.4 Korea Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7.5 India Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

8 South America Low Molecular Weight Heparin by Country

8.1 South America Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

8.1.1 South America Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

8.1.2 South America Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

8.2 Brazil Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

8.3 Argentina Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

8.4 Colombia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9 Middle East and Africa Low Molecular Weight Heparin by Countries

9.1 Middle East and Africa Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9.3 Turkey Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9.4 Egypt Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9.5 Nigeria Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9.6 South Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

10 Global Low Molecular Weight Heparin Market Segment by Type

10.1 Global Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Type (2014-2019)

10.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Type (2014-2019)

10.2 Enoxaparin Sales Growth and Price

10.2.1 Global Enoxaparin Sales Growth (2014-2019)

10.2.2 Global Enoxaparin Price (2014-2019)

10.3 Dalteparin Sales Growth and Price

10.3.1 Global Dalteparin Sales Growth (2014-2019)

10.3.2 Global Dalteparin Price (2014-2019)

10.4 Tinzaparin Sales Growth and Price

10.4.1 Global Tinzaparin Sales Growth (2014-2019)

10.4.2 Global Tinzaparin Price (2014-2019)

10.5 Fraxiparine Sales Growth and Price

10.5.1 Global Fraxiparine Sales Growth (2014-2019)

10.5.2 Global Fraxiparine Price (2014-2019)

11 Global Low Molecular Weight Heparin Market Segment by Application

11.1 Global Low Molecular Weight Heparin Sales Market Share by Application (2014-2019)

11.2 Treatment of Venous Thromboembolism Sales Growth (2014-2019)

11.3 Complications of Pregnancy Sales Growth (2014-2019)

11.4 Cardioversion of Atrial Fibrillation/Flutter Sales Growth (2014-2019)

11.5 Others Sales Growth (2014-2019)

12 Low Molecular Weight Heparin Market Forecast (2019-2024)

12.1 Global Low Molecular Weight Heparin Sales, Revenue and Growth Rate (2019-2024)

12.2 Low Molecular Weight Heparin Market Forecast by Regions (2019-2024)

12.2.1 North America Low Molecular Weight Heparin Market Forecast (2019-2024)

12.2.2 Europe Low Molecular Weight Heparin Market Forecast (2019-2024)

12.2.3 Asia-Pacific Low Molecular Weight Heparin Market Forecast (2019-2024)

12.2.4 South America Low Molecular Weight Heparin Market Forecast (2019-2024)

12.2.5 Middle East and Africa Low Molecular Weight Heparin Market Forecast (2019-2024)

12.3 Low Molecular Weight Heparin Market Forecast by Type (2019-2024)

12.3.1 Global Low Molecular Weight Heparin Sales Forecast by Type (2019-2024)

12.3.2 Global Low Molecular Weight Heparin Market Share Forecast by Type (2019-2024)

12.4 Low Molecular Weight Heparin Market Forecast by Application (2019-2024)

12.4.1 Global Low Molecular Weight Heparin Sales Forecast by Application (2019-2024)

12.4.2 Global Low Molecular Weight Heparin Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Low Molecular Weight Heparin Picture

Table Product Specifications of Low Molecular Weight Heparin

Figure Global Sales Market Share of Low Molecular Weight Heparin by Types in 2018

Table Low Molecular Weight Heparin Types for Major Manufacturers

Figure Enoxaparin Picture

Figure Dalteparin Picture

Figure Tinzaparin Picture

Figure Fraxiparine Picture

Figure Low Molecular Weight Heparin Sales Market Share by Applications in 2018

Figure Treatment of Venous Thromboembolism Picture

Figure Complications of Pregnancy Picture

Figure Cardioversion of Atrial Fibrillation/Flutter Picture

Figure Others Picture

Figure United States Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure France Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure UK Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure China Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure India Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Table Aspen Basic Information, Manufacturing Base and Competitors

Table Aspen Low Molecular Weight Heparin Type and Applications

Table Aspen Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Sanofi-aventis Basic Information, Manufacturing Base and Competitors

Table Sanofi-aventis Low Molecular Weight Heparin Type and Applications

Table Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Low Molecular Weight Heparin Type and Applications

Table Pfizer Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Opocrin Basic Information, Manufacturing Base and Competitors

Table Opocrin Low Molecular Weight Heparin Type and Applications

Table Opocrin Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table CSBIO Basic Information, Manufacturing Base and Competitors

Table CSBIO Low Molecular Weight Heparin Type and Applications

Table CSBIO Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Type and Applications

Table Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Changzhou Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors

Table Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Type and Applications

Table Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Techdow Basic Information, Manufacturing Base and Competitors

Table Techdow Low Molecular Weight Heparin Type and Applications

Table Techdow Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Yantai Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors

Table Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Type and Applications

Table Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Low Molecular Weight Heparin Sales by Manufacturer (2017-2018)

Figure Global Low Molecular Weight Heparin Sales Market Share by Manufacturer in 2017

Figure Global Low Molecular Weight Heparin Sales Market Share by Manufacturer in 2018

Table Global Low Molecular Weight Heparin Revenue by Manufacturer (2017-2018)

Figure Global Low Molecular Weight Heparin Revenue Market Share by Manufacturer in 2017

Figure Global Low Molecular Weight Heparin Revenue Market Share by Manufacturer in 2018

Figure Top 3 Low Molecular Weight Heparin Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Low Molecular Weight Heparin Manufacturer (Revenue) Market Share in 2018

Figure Global Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Global Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table Global Low Molecular Weight Heparin Sales by Regions (2014-2019)

Table Global Low Molecular Weight Heparin Sales Market Share by Regions (2014-2019)

Table Global Low Molecular Weight Heparin Revenue by Regions (2014-2019)

Figure Global Low Molecular Weight Heparin Revenue Market Share by Regions in 2014

Figure Global Low Molecular Weight Heparin Revenue Market Share by Regions in 2018

Figure North America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Europe Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure South America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure North America Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table North America Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table North America Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Figure North America Low Molecular Weight Heparin Sales Market Share by Countries in 2014

Figure North America Low Molecular Weight Heparin Sales Market Share by Countries in 2018

Table North America Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Table North America Low Molecular Weight Heparin Revenue Market Share by Countries (2014-2019)

Figure North America Low Molecular Weight Heparin Revenue Market Share by Countries in 2014

Figure North America Low Molecular Weight Heparin Revenue Market Share by Countries in 2018

Figure United States Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Canada Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Mexico Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Europe Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table Europe Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table Europe Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Table Europe Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Figure Europe Low Molecular Weight Heparin Revenue Market Share by Countries in 2017

Figure Europe Low Molecular Weight Heparin Revenue Market Share by Countries in 2018

Figure Germany Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure UK Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure France Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Russia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Italy Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table Asia-Pacific Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Low Molecular Weight Heparin Sales Market Share by Countries 2018

Table Asia-Pacific Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Figure Asia-Pacific Low Molecular Weight Heparin Revenue Market Share by Countries 2018

Figure China Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Japan Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Korea Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure India Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Southeast Asia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure South America Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table South America Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table South America Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Figure South America Low Molecular Weight Heparin Sales Market Share by Countries in 2018

Table South America Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Table South America Low Molecular Weight Heparin Revenue Market Share by Countries (2014-2019)

Figure South America Low Molecular Weight Heparin Revenue Market Share by Countries in 2018

Figure Brazil Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Argentina Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Colombia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Countries in 2018

Table Middle East and Africa Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Table Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Countries in 2014

Figure Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Countries in 2018

Figure Saudi Arabia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure UAE Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Egypt Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Nigeria Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure South Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Table Global Low Molecular Weight Heparin Sales by Type (2014-2019)

Table Global Low Molecular Weight Heparin Sales Share by Type (2014-2019)

Table Global Low Molecular Weight Heparin Revenue by Type (2014-2019)

Table Global Low Molecular Weight Heparin Revenue Share by Type (2014-2019)

Figure Global Enoxaparin Sales Growth (2014-2019)

Figure Global Enoxaparin Price (2014-2019)

Figure Global Dalteparin Sales Growth (2014-2019)

Figure Global Dalteparin Price (2014-2019)

Figure Global Tinzaparin Sales Growth (2014-2019)

Figure Global Tinzaparin Price (2014-2019)

Figure Global Fraxiparine Sales Growth (2014-2019)

Figure Global Fraxiparine Price (2014-2019)

Table Global Low Molecular Weight Heparin Sales by Application (2014-2019)

Table Global Low Molecular Weight Heparin Sales Share by Application (2014-2019)

Figure Global Complications of Pregnancy Sales Growth (2014-2019)

Figure Global Cardioversion of Atrial Fibrillation/Flutter Sales Growth (2014-2019)

Figure Global Others Sales Growth (2014-2019)

Figure Global Low Molecular Weight Heparin Sales, Revenue and Growth Rate (2019-2024)

Table Global Low Molecular Weight Heparin Sales Forecast by Regions (2019-2024)

Table Global Low Molecular Weight Heparin Market Share Forecast by Regions (2019-2024)

Figure North America Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Figure Europe Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Figure Asia-Pacific Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Figure South America Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Figure Middle East and Africa Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Table Global Low Molecular Weight Heparin Sales Forecast by Type (2019-2024)

Table Global Low Molecular Weight Heparin Market Share Forecast by Type (2019-2024)

Table Global Low Molecular Weight Heparin Sales Forecast by Application (2019-2024)

Table Global Low Molecular Weight Heparin Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Aspen

Sanofi-aventis

Pfizer

Opocrin

CSBIO

Dongying Tiandong Pharmaceutical

Changzhou Qianhong Bio-pharma

Techdow

Yantai Dongcheng Pharmaceutical Group

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

Scope of the Report:

In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second's largest market with the share of 30.49%.

At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.

China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.

In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.

Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.

The worldwide market for Low Molecular Weight Heparin is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 380 million USD in 2024, from 270 million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Low Molecular Weight Heparin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Aspen

Sanofi-aventis

Pfizer

Opocrin

CSBIO

Dongying Tiandong Pharmaceutical

Changzhou Qianhong Bio-pharma

Techdow

Yantai Dongcheng Pharmaceutical Group

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Enoxaparin

Dalteparin

Tinzaparin

Fraxiparine

Market Segment by Applications, can be divided into

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Low Molecular Weight Heparin product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin, with price, sales, revenue and global market share of Low Molecular Weight Heparin in 2017 and 2018.

Chapter 3, the Low Molecular Weight Heparin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Low Molecular Weight Heparin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Low Molecular Weight Heparin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Low Molecular Weight Heparin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Low Molecular Weight Heparin Introduction

1.2 Market Analysis by Type

1.2.1 Enoxaparin

1.2.2 Dalteparin

1.2.3 Tinzaparin

1.2.4 Fraxiparine

1.3 Market Analysis by Applications

1.3.1 Treatment of Venous Thromboembolism

1.3.2 Complications of Pregnancy

1.3.3 Cardioversion of Atrial Fibrillation/Flutter

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Aspen

2.1.1 Business Overview

2.1.2 Low Molecular Weight Heparin Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Aspen Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Sanofi-aventis

2.2.1 Business Overview

2.2.2 Low Molecular Weight Heparin Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Pfizer

2.3.1 Business Overview

2.3.2 Low Molecular Weight Heparin Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Opocrin

2.4.1 Business Overview

2.4.2 Low Molecular Weight Heparin Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 CSBIO

2.5.1 Business Overview

2.5.2 Low Molecular Weight Heparin Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Dongying Tiandong Pharmaceutical

2.6.1 Business Overview

2.6.2 Low Molecular Weight Heparin Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Changzhou Qianhong Bio-pharma

2.7.1 Business Overview

2.7.2 Low Molecular Weight Heparin Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Techdow

2.8.1 Business Overview

2.8.2 Low Molecular Weight Heparin Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Techdow Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Yantai Dongcheng Pharmaceutical Group

2.9.1 Business Overview

2.9.2 Low Molecular Weight Heparin Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Low Molecular Weight Heparin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Low Molecular Weight Heparin Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Low Molecular Weight Heparin Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Low Molecular Weight Heparin Manufacturer Market Share in 2018

3.3.2 Top 6 Low Molecular Weight Heparin Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Low Molecular Weight Heparin Market Analysis by Regions

4.1 Global Low Molecular Weight Heparin Sales, Revenue and Market Share by Regions

4.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Regions (2014-2019)

4.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Regions (2014-2019)

4.2 North America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

4.3 Europe Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

4.5 South America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

5 North America Low Molecular Weight Heparin by Country

5.1 North America Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

5.1.1 North America Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

5.1.2 North America Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

5.2 United States Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

5.3 Canada Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

5.4 Mexico Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6 Europe Low Molecular Weight Heparin by Country

6.1 Europe Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

6.1.1 Europe Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

6.1.2 Europe Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

6.2 Germany Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6.3 UK Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6.4 France Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6.5 Russia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

6.6 Italy Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7 Asia-Pacific Low Molecular Weight Heparin by Country

7.1 Asia-Pacific Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

7.2 China Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7.3 Japan Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7.4 Korea Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7.5 India Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

8 South America Low Molecular Weight Heparin by Country

8.1 South America Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

8.1.1 South America Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

8.1.2 South America Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

8.2 Brazil Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

8.3 Argentina Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

8.4 Colombia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9 Middle East and Africa Low Molecular Weight Heparin by Countries

9.1 Middle East and Africa Low Molecular Weight Heparin Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9.3 Turkey Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9.4 Egypt Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9.5 Nigeria Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

9.6 South Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

10 Global Low Molecular Weight Heparin Market Segment by Type

10.1 Global Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Type (2014-2019)

10.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Type (2014-2019)

10.2 Enoxaparin Sales Growth and Price

10.2.1 Global Enoxaparin Sales Growth (2014-2019)

10.2.2 Global Enoxaparin Price (2014-2019)

10.3 Dalteparin Sales Growth and Price

10.3.1 Global Dalteparin Sales Growth (2014-2019)

10.3.2 Global Dalteparin Price (2014-2019)

10.4 Tinzaparin Sales Growth and Price

10.4.1 Global Tinzaparin Sales Growth (2014-2019)

10.4.2 Global Tinzaparin Price (2014-2019)

10.5 Fraxiparine Sales Growth and Price

10.5.1 Global Fraxiparine Sales Growth (2014-2019)

10.5.2 Global Fraxiparine Price (2014-2019)

11 Global Low Molecular Weight Heparin Market Segment by Application

11.1 Global Low Molecular Weight Heparin Sales Market Share by Application (2014-2019)

11.2 Treatment of Venous Thromboembolism Sales Growth (2014-2019)

11.3 Complications of Pregnancy Sales Growth (2014-2019)

11.4 Cardioversion of Atrial Fibrillation/Flutter Sales Growth (2014-2019)

11.5 Others Sales Growth (2014-2019)

12 Low Molecular Weight Heparin Market Forecast (2019-2024)

12.1 Global Low Molecular Weight Heparin Sales, Revenue and Growth Rate (2019-2024)

12.2 Low Molecular Weight Heparin Market Forecast by Regions (2019-2024)

12.2.1 North America Low Molecular Weight Heparin Market Forecast (2019-2024)

12.2.2 Europe Low Molecular Weight Heparin Market Forecast (2019-2024)

12.2.3 Asia-Pacific Low Molecular Weight Heparin Market Forecast (2019-2024)

12.2.4 South America Low Molecular Weight Heparin Market Forecast (2019-2024)

12.2.5 Middle East and Africa Low Molecular Weight Heparin Market Forecast (2019-2024)

12.3 Low Molecular Weight Heparin Market Forecast by Type (2019-2024)

12.3.1 Global Low Molecular Weight Heparin Sales Forecast by Type (2019-2024)

12.3.2 Global Low Molecular Weight Heparin Market Share Forecast by Type (2019-2024)

12.4 Low Molecular Weight Heparin Market Forecast by Application (2019-2024)

12.4.1 Global Low Molecular Weight Heparin Sales Forecast by Application (2019-2024)

12.4.2 Global Low Molecular Weight Heparin Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Low Molecular Weight Heparin Picture

Table Product Specifications of Low Molecular Weight Heparin

Figure Global Sales Market Share of Low Molecular Weight Heparin by Types in 2018

Table Low Molecular Weight Heparin Types for Major Manufacturers

Figure Enoxaparin Picture

Figure Dalteparin Picture

Figure Tinzaparin Picture

Figure Fraxiparine Picture

Figure Low Molecular Weight Heparin Sales Market Share by Applications in 2018

Figure Treatment of Venous Thromboembolism Picture

Figure Complications of Pregnancy Picture

Figure Cardioversion of Atrial Fibrillation/Flutter Picture

Figure Others Picture

Figure United States Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure France Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure UK Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure China Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure India Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Low Molecular Weight Heparin Revenue (Value) and Growth Rate (2014-2024)

Table Aspen Basic Information, Manufacturing Base and Competitors

Table Aspen Low Molecular Weight Heparin Type and Applications

Table Aspen Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Sanofi-aventis Basic Information, Manufacturing Base and Competitors

Table Sanofi-aventis Low Molecular Weight Heparin Type and Applications

Table Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Low Molecular Weight Heparin Type and Applications

Table Pfizer Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Opocrin Basic Information, Manufacturing Base and Competitors

Table Opocrin Low Molecular Weight Heparin Type and Applications

Table Opocrin Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table CSBIO Basic Information, Manufacturing Base and Competitors

Table CSBIO Low Molecular Weight Heparin Type and Applications

Table CSBIO Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Type and Applications

Table Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Changzhou Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors

Table Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Type and Applications

Table Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Techdow Basic Information, Manufacturing Base and Competitors

Table Techdow Low Molecular Weight Heparin Type and Applications

Table Techdow Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Yantai Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors

Table Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Type and Applications

Table Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Low Molecular Weight Heparin Sales by Manufacturer (2017-2018)

Figure Global Low Molecular Weight Heparin Sales Market Share by Manufacturer in 2017

Figure Global Low Molecular Weight Heparin Sales Market Share by Manufacturer in 2018

Table Global Low Molecular Weight Heparin Revenue by Manufacturer (2017-2018)

Figure Global Low Molecular Weight Heparin Revenue Market Share by Manufacturer in 2017

Figure Global Low Molecular Weight Heparin Revenue Market Share by Manufacturer in 2018

Figure Top 3 Low Molecular Weight Heparin Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Low Molecular Weight Heparin Manufacturer (Revenue) Market Share in 2018

Figure Global Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Global Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table Global Low Molecular Weight Heparin Sales by Regions (2014-2019)

Table Global Low Molecular Weight Heparin Sales Market Share by Regions (2014-2019)

Table Global Low Molecular Weight Heparin Revenue by Regions (2014-2019)

Figure Global Low Molecular Weight Heparin Revenue Market Share by Regions in 2014

Figure Global Low Molecular Weight Heparin Revenue Market Share by Regions in 2018

Figure North America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Europe Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure South America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure North America Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table North America Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table North America Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Figure North America Low Molecular Weight Heparin Sales Market Share by Countries in 2014

Figure North America Low Molecular Weight Heparin Sales Market Share by Countries in 2018

Table North America Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Table North America Low Molecular Weight Heparin Revenue Market Share by Countries (2014-2019)

Figure North America Low Molecular Weight Heparin Revenue Market Share by Countries in 2014

Figure North America Low Molecular Weight Heparin Revenue Market Share by Countries in 2018

Figure United States Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Canada Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Mexico Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Europe Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table Europe Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table Europe Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Table Europe Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Figure Europe Low Molecular Weight Heparin Revenue Market Share by Countries in 2017

Figure Europe Low Molecular Weight Heparin Revenue Market Share by Countries in 2018

Figure Germany Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure UK Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure France Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Russia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Italy Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table Asia-Pacific Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Low Molecular Weight Heparin Sales Market Share by Countries 2018

Table Asia-Pacific Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Figure Asia-Pacific Low Molecular Weight Heparin Revenue Market Share by Countries 2018

Figure China Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Japan Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Korea Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure India Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Southeast Asia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure South America Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table South America Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table South America Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Figure South America Low Molecular Weight Heparin Sales Market Share by Countries in 2018

Table South America Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Table South America Low Molecular Weight Heparin Revenue Market Share by Countries (2014-2019)

Figure South America Low Molecular Weight Heparin Revenue Market Share by Countries in 2018

Figure Brazil Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Argentina Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Colombia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Low Molecular Weight Heparin Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Low Molecular Weight Heparin Sales by Countries (2014-2019)

Table Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Countries in 2018

Table Middle East and Africa Low Molecular Weight Heparin Revenue by Countries (2014-2019)

Table Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Countries in 2014

Figure Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Countries in 2018

Figure Saudi Arabia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure UAE Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Egypt Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure Nigeria Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Figure South Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

Table Global Low Molecular Weight Heparin Sales by Type (2014-2019)

Table Global Low Molecular Weight Heparin Sales Share by Type (2014-2019)

Table Global Low Molecular Weight Heparin Revenue by Type (2014-2019)

Table Global Low Molecular Weight Heparin Revenue Share by Type (2014-2019)

Figure Global Enoxaparin Sales Growth (2014-2019)

Figure Global Enoxaparin Price (2014-2019)

Figure Global Dalteparin Sales Growth (2014-2019)

Figure Global Dalteparin Price (2014-2019)

Figure Global Tinzaparin Sales Growth (2014-2019)

Figure Global Tinzaparin Price (2014-2019)

Figure Global Fraxiparine Sales Growth (2014-2019)

Figure Global Fraxiparine Price (2014-2019)

Table Global Low Molecular Weight Heparin Sales by Application (2014-2019)

Table Global Low Molecular Weight Heparin Sales Share by Application (2014-2019)

Figure Global Complications of Pregnancy Sales Growth (2014-2019)

Figure Global Cardioversion of Atrial Fibrillation/Flutter Sales Growth (2014-2019)

Figure Global Others Sales Growth (2014-2019)

Figure Global Low Molecular Weight Heparin Sales, Revenue and Growth Rate (2019-2024)

Table Global Low Molecular Weight Heparin Sales Forecast by Regions (2019-2024)

Table Global Low Molecular Weight Heparin Market Share Forecast by Regions (2019-2024)

Figure North America Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Figure Europe Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Figure Asia-Pacific Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Figure South America Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Figure Middle East and Africa Sales Low Molecular Weight Heparin Market Forecast (2019-2024)

Table Global Low Molecular Weight Heparin Sales Forecast by Type (2019-2024)

Table Global Low Molecular Weight Heparin Market Share Forecast by Type (2019-2024)

Table Global Low Molecular Weight Heparin Sales Forecast by Application (2019-2024)

Table Global Low Molecular Weight Heparin Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Aspen

Sanofi-aventis

Pfizer

Opocrin

CSBIO

Dongying Tiandong Pharmaceutical

Changzhou Qianhong Bio-pharma

Techdow

Yantai Dongcheng Pharmaceutical Group